Publications by authors named "Maria-Laura Fox"

Claim this Profile
C
Coexisting Myeloproliferative and Lymphoid Neoplasms: A European Multicenter Retrospective Study.
Dolly Viviana Fiallo-Suárez, Ruth Stuckey, Cristina Bilbao-Sieyro, María Tapia Torres, Leonor Pérez-Ortíz, María Laura Fox

Am J Hematol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mepolizumab for hypereosinophilic syndrome: effectiveness and safety from real-world evidence.
Elvira Mora, María Laura Fox, Angelina Lemes, Beatriz Velasco, Jesús María Hernández-Rivas

Front Immunol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
J
JAK inhibitor selection in challenging scenarios of myelofibrosis: a review.
Pankit Vachhani, Ruben Mesa, John Mascarenhas, Raajit Rampal, Stephen T Oh, Maria Laura Fox

Haematologica· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real world outcomes of momelotinib in myelofibrosis patients with anemia: results from the MOMGEMFIN study.
Lucía Pérez-Lamas, Adrián Segura Diaz, Regina García Delgado, Alberto Álvarez-Larrán, María Alicia Senin, María Laura Fox

Blood Cancer J· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal Assessment of Transfusion Intensity in Patients With JAK Inhibitor-Naive or -Experienced Myelofibrosis Treated With Momelotinib.
Claire N Harrison, Ruben Mesa, Moshe Talpaz, Vikas Gupta, Aaron T Gerds, Maria Laura Fox

Clin Lymphoma Myeloma Leuk· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of somatic gene mutations on the risk of thrombosis in myelofibrosis.
Irene Pastor-Galán, Arturo Pereira, Eduardo Arellano-Rodrigo, Iván Martín, Adrián Mosquera-Orgueira, María-Laura Fox

Leukemia· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Post-transplant cyclophosphamide compared to sirolimus/tacrolimus in reduced intensity conditioning transplants for patients with lymphoid malignancies.
Maria Laura Fox, Irene García-Cadenas, Victor Navarro, Ariadna Pérez Martínez, Meriem Kara

Bone Marrow Transplant· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Meaningful Symptomatic Change in Patients With Myelofibrosis From the SIMPLIFY Studies.
Stacie Hudgens, Srdan Verstovsek, Lysbeth Floden, Claire N Harrison, Jeanne Palmer, Maria Laura Fox

Value Health· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The prognostic impact of non-driver gene mutations and variant allele frequency in primary myelofibrosis.
Alberto Hernández-Sánchez, Ángela Villaverde-Ramiro, Eduardo Arellano-Rodrigo, Marta Garrote, Iván Martín, María-Laura Fox

Am J Hematol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrating AIPSS-MF and molecular predictors: A comparative analysis of prognostic models for myelofibrosis.
Adrián Mosquera-Orgueira, Eduardo Arellano-Rodrigo, Marta Garrote, Iván Martín, Manuel Pérez-Encinas, María-Laura Fox

Hemasphere· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changes in bone marrow fibrosis during momelotinib or ruxolitinib therapy do not correlate with efficacy outcomes in patients with myelofibrosis.
Stephen T Oh, Srdan Verstovsek, Vikas Gupta, Uwe Platzbecker, Timothy Devos, Maria Laura Fox

EJHaem· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-reported Outcomes and Quality of Life in Anemic and Symptomatic Patients With Myelofibrosis: Results From the MOMENTUM Study.
Ruben A Mesa, Claire Harrison, Jeanne M Palmer, Vikas Gupta, Donal P McLornan, Maria Laura Fox

Hemasphere· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis previously treated with a JAK inhibitor (MOMENTUM): an updated analysis of an international, double-blind, randomised phase 3 study.
Aaron T Gerds, Srdan Verstovsek, Alessandro M Vannucchi, Haifa Kathrin Al-Ali, David Lavie, Maria Laura Fox

Lancet Haematol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of the potential value of plasma Torque Teno virus DNA load monitoring to predict cytomegalovirus DNAemia in patients with hematological malignancies treated with small molecule inhibitors: A proof-of-concept study.
Carlos Solano de la Asunción, Estela Giménez, Juan Carlos Hernández-Boluda, María José Terol, Eliseo Albert, María Laura Fox

J Med Virol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunobiology of cytomegalovirus infection in patients with haematological malignancies undergoing treatment with small molecule inhibitors.
Solano de la Asunción Carlos, Estela Giménez, Juan Carlos Hernández-Boluda, María José Terol, Eliseo Albert, María Laura Fox

Br J Haematol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Philadelphia-negative chronic myeloproliferative neoplasm follow-up: when the phone rings. Changes during the COVID-19 pandemic and patient satisfaction. Experience in 30 health centers in Spain.
Ariana Ortuzar, María Laura Fox, Juan Antonio Vera, Álvaro Lorenzo Vizcaya, Alberto Marín Sánchez

Ann Hematol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Machine Learning Improves Risk Stratification in Myelofibrosis: An Analysis of the Spanish Registry of Myelofibrosis.
Adrián Mosquera-Orgueira, Manuel Pérez-Encinas, Alberto Hernández-Sánchez, Teresa González-Martínez, Eduardo Arellano-Rodrigo, María-Laura Fox

Hemasphere· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study.
Srdan Verstovsek, Aaron T Gerds, Alessandro M Vannucchi, Haifa Kathrin Al-Ali, David Lavie, Maria Laura Fox

Lancet· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determinants of early triage for hospitalization in myeloproliferative neoplasm (MPN) patients with COVID-19.
Tiziano Barbui, Alessandra Carobbio, Arianna Ghirardi, Alessandra Iurlo, Marta Anna Sobas, Maria Laura Fox

Am J Hematol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of thrombosis and bleeding in 1613 myelofibrosis patients from the Spanish Registry of Myelofibrosis.
Juan-Carlos Hernández-Boluda, Irene Pastor-Galán, Eduardo Arellano-Rodrigo, José-María Raya, Manuel Pérez-Encinas, María-Laura Fox

Br J Haematol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hematopoietic stem cell transplantation for adolescents and adults with inborn errors of immunity: an EBMT IEWP study.
Michael H Albert, Tiarlan Sirait, Dirk-Jan Eikema, Katerina Bakunina, Claudia Wehr, Maria Laura Fox

Blood· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Post thawing viable CD34+ Cells dose is a better predictor of clinical outcome in lymphoma patients undergoing autologous stem cell transplantation.
Jesus Fernandez-Sojo, Joan Cid, Carmen Azqueta, Elena Valdivia, Lluis Martorell, Maria Laura Fox

Bone Marrow Transplant· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world analysis of main clinical outcomes in patients with polycythemia vera treated with ruxolitinib or best available therapy after developing resistance/intolerance to hydroxyurea.
Alberto Alvarez-Larrán, Marta Garrote, Francisca Ferrer-Marín, Manuel Pérez-Encinas, M Isabel Mata-Vazquez, Maria Laura Fox

Cancer· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Second versus first wave of COVID-19 in patients with MPN.
Tiziano Barbui, Alessandra Iurlo, Arianna Masciulli, Alessandra Carobbio, Arianna Ghirardi, Maria Laura Fox

Leukemia· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term follow-up of recovered MPN patients with COVID-19.
Tiziano Barbui, Alessandra Iurlo, Arianna Masciulli, Alessandra Carobbio, Arianna Ghirardi, Maria Laura Fox

Blood Cancer J· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis